9902.07.41 - [(7R)-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4- diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2- yl)phenyl]methanone (Suvorexant) (CAS No. 1030377-33-3) (provided for in subheading 2934.99.30)

This HTS category, 9902.07.41, specifically classifies the pharmaceutical compound known as Suvorexant (CAS No. 1030377-33-3). The detailed chemical nomenclature provided, [(7R)-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone, serves to precisely identify this specific active pharmaceutical ingredient. This classification is made within the framework of Chapter 99, which encompasses temporary legislation and special provisions, indicating that its inclusion here is subject to specific import regulations and potential modifications.

As this is a leaf node within the HTS database, there are no further subcategories to explore. Its purpose is to provide a unique identifier for Suvorexant, distinct from broader classifications of chemicals or pharmaceuticals. The reference to its provision for in subheading 2934.99.30 highlights its origin within the "Other heterocyclic compounds" chapter before being specifically designated under this temporary provision. This distinction ensures that import duties and regulations applied to Suvorexant are handled with precision, reflecting its specific status under trade agreements and temporary legislation.